{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:56:25Z","timestamp":1793228185041,"version":"4.5.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>Most biomarker studies of sepsis originate from high-income countries, whereas mortality risk is higher in low- and middle-income countries. The second version of the Pediatric Sepsis Biomarker Risk Model (PERSEVERE-II) has been validated in multiple North American PICUs for prognosis. Given differences in epidemiology, we assessed the performance of PERSEVERE-II in septic children from Pakistan, a low-middle income country. Due to uncertainty regarding how well PERSEVERE-II would perform, we also assessed the utility of other select biomarkers reflecting endotheliopathy, coagulopathy, and lung injury.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Prospective cohort study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>PICU in Aga Khan University Hospital in Karachi, Pakistan.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>Children (&lt; 18 yr old) meeting pediatric modifications of adult Sepsis-3 criteria between November 2020 and February 2022 were eligible.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Measurements and Main Results:<\/jats:title>\n            <jats:p>Plasma was collected within 24 hours of admission and biomarkers quantified. The area under the receiver operating characteristic curve for PERSEVERE-II to discriminate 28-day mortality was determined. Additional biomarkers were compared between survivors and nonsurvivors and between subjects with and without acute respiratory distress syndrome. In 86 subjects (20 nonsurvivors, 23%), PERSEVERE-II discriminated mortality (area under the receiver operating characteristic curve, 0.83; 95% CI, 0.72\u20130.94) and stratified the cohort into low-, medium-, and high-risk of mortality. Biomarkers reflecting endotheliopathy (angiopoietin 2, intracellular adhesion molecule 1) increased across worsening risk strata. Angiopoietin 2, soluble thrombomodulin, and plasminogen activator inhibitor 1 were higher in nonsurvivors, and soluble receptor for advanced glycation end-products and surfactant protein D were higher in children meeting acute respiratory distress syndrome criteria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>PERSEVERE-II performs well in septic children from Aga Khan University Hospital, representing the first validation of PERSEVERE-II in a low-middle income country. Patients possessed a biomarker profile comparable to that of sepsis from high-income countries, suggesting that biomarker-based enrichment strategies may be effective in this setting.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pcc.0000000000003244","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T13:00:36Z","timestamp":1682341236000},"page":"563-573","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Biomarker-Based Risk Stratification in Pediatric Sepsis From a Low-Middle Income Country*"],"prefix":"10.1097","volume":"24","author":[{"given":"Sidra","family":"Ishaque","sequence":"first","affiliation":[{"name":"Department of Pediatrics and Child Health, The Aga Khan University Hospital, Karachi, Pakistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen Thomas","family":"Famularo","sequence":"additional","affiliation":[{"name":"Division of Pediatric Critical Care Medicine, Department of Anesthesiology and Critical Care, University of Pennsylvania and Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Faisal","family":"Saleem","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Child Health, The Aga Khan University Hospital, Karachi, Pakistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed Ur Rehman","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Child Health, The Aga Khan University Hospital, Karachi, Pakistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaubina","family":"Kazi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Child Health, The Aga Khan University Hospital, Karachi, Pakistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Parkar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Child Health, The Aga Khan University Hospital, Karachi, Pakistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneeta","family":"Hotwani","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Child Health, The Aga Khan University Hospital, Karachi, Pakistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal J.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Division of Pediatric Critical Care Medicine, Department of Pediatrics, Penn State University College of Medicine, Hershey, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill Marie","family":"Thompson","sequence":"additional","affiliation":[{"name":"Division of Pediatric Critical Care Medicine, Department of Anesthesiology and Critical Care, University of Pennsylvania and Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Lahni","sequence":"additional","affiliation":[{"name":"Division of Pediatric Critical Care Medicine, Department of Pediatrics, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Varisco","sequence":"additional","affiliation":[{"name":"Division of Pediatric Critical Care Medicine, Department of Pediatrics, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH."},{"name":"University of Cincinnati College of Medicine, Cincinnati, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadir","family":"Yehya","sequence":"additional","affiliation":[{"name":"Division of Pediatric Critical Care Medicine, Department of Anesthesiology and Critical Care, University of Pennsylvania and Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4,24]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: Analysis for the Global Burden of Disease Study.","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S2213-2600(18)30063-8","article-title":"The global burden of paediatric and neonatal sepsis: A systematic review.","volume":"6","author":"Fleischmann-Struzek","year":"2018","journal-title":"Lancet Respir Med"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/S0140-6736(10)60549-1","article-title":"Global, regional, and national causes of child mortality in 2008: A systematic analysis.","volume":"375","author":"Black","year":"2010","journal-title":"Lancet"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0140-6736(14)61698-6","article-title":"Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: An updated systematic analysis.","volume":"385","author":"Liu","year":"2015","journal-title":"Lancet"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1164\/rccm.201412-2323OC","article-title":"Global epidemiology of pediatric severe sepsis: The sepsis prevalence, outcomes, and therapies study.","volume":"191","author":"Weiss","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1164\/rccm.201611-2307OC","article-title":"A two-biomarker model predicts mortality in the critically ill with sepsis.","volume":"196","author":"Mikacenic","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2213-2600(17)30294-1","article-title":"Classification of patients with sepsis according to blood genomic endotype: A prospective cohort study.","volume":"5","author":"Scicluna","year":"2017","journal-title":"Lancet Respir Med"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41467-018-03078-2","article-title":"A community approach to mortality prediction in sepsis via gene expression analysis.","volume":"9","author":"Sweeney","year":"2018","journal-title":"Nat Commun"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jama.2016.0289","article-title":"Developing a new definition and assessing new clinical criteria for septic shock: For the third international consensus definitions for sepsis and septic shock (Sepsis-3).","volume":"315","author":"Shankar-Hari","year":"2016","journal-title":"JAMA"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2019.5791","article-title":"Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis.","volume":"321","author":"Seymour","year":"2019","journal-title":"JAMA"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1164\/rccm.201411-2125CP","article-title":"Implications of heterogeneity of treatment effect for reporting and analysis of randomized trials in critical care.","volume":"192","author":"Iwashyna","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s00134-020-05934-6","article-title":"Contemporary strategies to improve clinical trial design for critical care research: Insights from the First Critical Care Clinical Trialists Workshop.","volume":"46","author":"Harhay","year":"2020","journal-title":"Intensive Care Med"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"R174","DOI":"10.1186\/cc11652","article-title":"The pediatric sepsis biomarker risk model.","volume":"16","author":"Wong","year":"2012","journal-title":"Crit Care"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1097\/CCM.0000000000001852","article-title":"Pediatric sepsis biomarker risk model-II: Redefining the pediatric sepsis biomarker risk model with septic shock phenotype.","volume":"44","author":"Wong","year":"2016","journal-title":"Crit Care Med"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-2600(18)30177-2","article-title":"Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: Secondary analysis of a randomised controlled trial.","volume":"6","author":"Calfee","year":"2018","journal-title":"Lancet Respir Med"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00134-018-5378-3","article-title":"Latent class analysis of ARDS subphenotypes: A secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study.","volume":"44","author":"Sinha","year":"2018","journal-title":"Intensive Care Med"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1097\/CCM.0000000000004710","article-title":"Practitioner\u2019s guide to latent class analysis: Methodological considerations and common pitfalls.","volume":"49","author":"Sinha","year":"2021","journal-title":"Crit Care Med"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/thoraxjnl-2021-217158","article-title":"Latent class analysis-derived subphenotypes are generalisable to observational cohorts of acute respiratory distress syndrome: A prospective study.","volume":"77","author":"Sinha","year":"2022","journal-title":"Thorax"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1164\/rccm.201512-2544CP","article-title":"Toward smarter lumping and smarter splitting: Rethinking strategies for sepsis and acute respiratory distress syndrome clinical trial design.","volume":"194","author":"Prescott","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"R21-20250502","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax9000","article-title":"Prospective clinical testing and experimental validation of the Pediatric Sepsis Biomarker Risk Model.","volume":"11","author":"Wong","year":"2019","journal-title":"Sci Transl Med"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13054-022-04070-5","article-title":"Integrated PERSEVERE and endothelial biomarker risk model predicts death and persistent MODS in pediatric septic shock: A secondary analysis of a prospective observational study.","volume":"26","author":"Atreya","year":"2022","journal-title":"Crit Care"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1007\/s00134-020-06010-9","article-title":"Acute respiratory distress syndrome-attributable mortality in critically ill patients with sepsis.","volume":"46","author":"Auriemma","year":"2020","journal-title":"Intensive Care Med"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1164\/rccm.200509-1477OC","article-title":"Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury.","volume":"173","author":"Uchida","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/thorax.58.11.983","article-title":"Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury.","volume":"58","author":"Eisner","year":"2003","journal-title":"Thorax"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"e172352","DOI":"10.1001\/jamapediatrics.2017.2352","article-title":"Adaptation and validation of a pediatric Sequential Organ Failure Assessment score and evaluation of the Sepsis-3 definitions in critically ill children.","volume":"171","author":"Matics","year":"2017","journal-title":"JAMA Pediatr"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/PCC.0000000000000350","article-title":"Pediatric acute respiratory distress syndrome: Consensus recommendations from the Pediatric Acute Lung Injury Consensus Conference.","volume":"16","year":"2015","journal-title":"Pediatr Crit Care Med"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/CCM.0b013e31828a2bbd","article-title":"PELOD-2: An update of the PEdiatric logistic organ dysfunction score.","volume":"41","author":"Leteurtre","year":"2013","journal-title":"Crit Care Med"},{"key":"R29-20250502","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/PCC.0b013e3181b806fc","article-title":"Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass.","volume":"11","author":"Gaies","year":"2010","journal-title":"Pediatr Crit Care Med"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"e514","DOI":"10.1097\/CCM.0000000000004345","article-title":"Predicting mortality in children with pediatric acute respiratory distress syndrome: A pediatric acute respiratory distress syndrome incidence and epidemiology study.","volume":"48","author":"Yehya","year":"2020","journal-title":"Crit Care Med"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2431-13-44","article-title":"Deficiency of ADAMTS-13 in pediatric patients with severe sepsis and impact on in-hospital mortality.","volume":"13","author":"Karim","year":"2013","journal-title":"BMC Pediatr"},{"key":"R32-20250502","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/CCM.0b013e318206d285","article-title":"Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis.","volume":"39","author":"Ricciuto","year":"2011","journal-title":"Crit Care Med"},{"key":"R33-20250502","doi-asserted-by":"crossref","first-page":"e0182324","DOI":"10.1371\/journal.pone.0182324","article-title":"Increased serum thrombomodulin level is associated with disease severity and mortality in pediatric sepsis.","volume":"12","author":"Lin","year":"2017","journal-title":"PLoS One"},{"key":"R34-20250502","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3389\/fimmu.2018.01218","article-title":"Plasminogen activator inhibitor 1 for predicting sepsis severity and mortality outcomes: A systematic review and meta-analysis.","volume":"9","author":"Tipoe","year":"2018","journal-title":"Front Immunol"},{"key":"R35-20250502","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13054-021-03474-z","article-title":"Angiopoietin-2 outperforms other endothelial biomarkers associated with severe acute kidney injury in patients with severe sepsis and respiratory failure.","volume":"25","author":"Yu","year":"2021","journal-title":"Crit Care"},{"key":"R36-20250502","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/CCM.0b013e318206b3ca","article-title":"Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients.","volume":"39","author":"Jabaudon","year":"2011","journal-title":"Crit Care Med"},{"key":"R37-20250502","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1164\/rccm.201810-2033OC","article-title":"Plasma sRAGE acts as a genetically regulated causal intermediate in sepsis-associated acute respiratory distress syndrome.","volume":"201","author":"Jones","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"R38-20250502","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/CCM.0000000000005373","article-title":"Beyond the alveolar epithelium: Plasma soluble receptor for advanced glycation end products is associated with oxygenation impairment, mortality, and extrapulmonary organ failure in children with acute respiratory distress syndrome.","volume":"50","author":"Lim","year":"2022","journal-title":"Crit Care Med"},{"key":"R39-20250502","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1164\/rccm.201501-0020OC","article-title":"Soluble receptor for advanced glycation end-products predicts impaired alveolar fluid clearance in acute respiratory distress syndrome.","volume":"192","author":"Jabaudon","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"R40-20250502","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.chest.2020.03.041","article-title":"Surfactant protein D is associated with severe pediatric ARDS, prolonged ventilation, and death in children with acute respiratory failure.","volume":"158","author":"Dahmer","year":"2020","journal-title":"Chest"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003244","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T17:16:12Z","timestamp":1746206172000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,24]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000003244","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,24]]}}}